These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 20670981

  • 1. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.
    Calabrese M, Rinaldi F, Grossi P, Mattisi I, Bernardi V, Favaretto A, Perini P, Gallo P.
    Mult Scler; 2010 Oct; 16(10):1220-8. PubMed ID: 20670981
    [Abstract] [Full Text] [Related]

  • 2. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways.
    Sepulcre J, Masdeu JC, Goñi J, Arrondo G, Vélez de Mendizábal N, Bejarano B, Villoslada P.
    Mult Scler; 2009 Mar; 15(3):337-44. PubMed ID: 18987107
    [Abstract] [Full Text] [Related]

  • 3. Structural and cognitive correlates of fatigue in progressive multiple sclerosis.
    Andreasen AK, Iversen P, Marstrand L, Siersma V, Siebner HR, Sellebjerg F.
    Neurol Res; 2019 Feb; 41(2):168-176. PubMed ID: 30513278
    [Abstract] [Full Text] [Related]

  • 4. Resting-state functional connectivity networks associated with fatigue in multiple sclerosis with early age onset.
    Stefancin P, Govindarajan ST, Krupp L, Charvet L, Duong TQ.
    Mult Scler Relat Disord; 2019 Jun; 31():101-105. PubMed ID: 30954931
    [Abstract] [Full Text] [Related]

  • 5. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X, Yang T, Cheng F, Yang S, Zhu W, Li S, Fan Y.
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
    Nygaard GO, Walhovd KB, Sowa P, Chepkoech JL, Bjørnerud A, Due-Tønnessen P, Landrø NI, Damangir S, Spulber G, Storsve AB, Beyer MK, Fjell AM, Celius EG, Harbo HF.
    Mult Scler; 2015 Apr; 21(4):402-14. PubMed ID: 25139946
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal associations between brain structural changes and fatigue in early MS.
    Nourbakhsh B, Azevedo C, Nunan-Saah J, Maghzi AH, Spain R, Pelletier D, Waubant E.
    Mult Scler Relat Disord; 2016 Jan; 5():29-33. PubMed ID: 26856940
    [Abstract] [Full Text] [Related]

  • 11. Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study.
    Codella M, Rocca MA, Colombo B, Martinelli-Boneschi F, Comi G, Filippi M.
    J Neurol Sci; 2002 Feb 15; 194(1):71-4. PubMed ID: 11809169
    [Abstract] [Full Text] [Related]

  • 12. Atrophy of reward-related striatal structures in fatigued MS patients is independent of physical disability.
    Damasceno A, Damasceno BP, Cendes F.
    Mult Scler; 2016 May 15; 22(6):822-9. PubMed ID: 26238465
    [Abstract] [Full Text] [Related]

  • 13. Fatigue and brain atrophy in Egyptian patients with relapsing remitting multiple sclerosis.
    Khedr EM, Desoky T, Gamea A, Ezzeldin MY, Zaki AF.
    Mult Scler Relat Disord; 2022 Jul 15; 63():103841. PubMed ID: 35526475
    [Abstract] [Full Text] [Related]

  • 14. Fatigue in multiple sclerosis: The contribution of occult white matter damage.
    Bisecco A, Caiazzo G, d'Ambrosio A, Sacco R, Bonavita S, Docimo R, Cirillo M, Pagani E, Filippi M, Esposito F, Tedeschi G, Gallo A.
    Mult Scler; 2016 Nov 15; 22(13):1676-1684. PubMed ID: 26846989
    [Abstract] [Full Text] [Related]

  • 15. Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.
    Hojjat SP, Cantrell CG, Vitorino R, Feinstein A, Shirzadi Z, MacIntosh BJ, Crane DE, Zhang L, Morrow SA, Lee L, O'Connor P, Carroll TJ, Aviv RI.
    Mult Scler; 2016 Oct 15; 22(11):1421-1428. PubMed ID: 26754799
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.
    Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P.
    Mult Scler; 2012 Dec 15; 18(12):1760-7. PubMed ID: 22570359
    [Abstract] [Full Text] [Related]

  • 18. Regional brain atrophy in primary fatigued patients with multiple sclerosis.
    Andreasen AK, Jakobsen J, Soerensen L, Andersen H, Petersen T, Bjarkam CR, Ahdidan J.
    Neuroimage; 2010 Apr 01; 50(2):608-15. PubMed ID: 20060048
    [Abstract] [Full Text] [Related]

  • 19. Multiple sclerosis-related fatigue: Altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex.
    Jaeger S, Paul F, Scheel M, Brandt A, Heine J, Pach D, Witt CM, Bellmann-Strobl J, Finke C.
    Mult Scler; 2019 Apr 01; 25(4):554-564. PubMed ID: 29464981
    [Abstract] [Full Text] [Related]

  • 20. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
    Hofstetter L, Naegelin Y, Filli L, Kuster P, Traud S, Smieskova R, Mueller-Lenke N, Kappos L, Gass A, Sprenger T, Penner IK, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K.
    Mult Scler; 2014 Feb 01; 20(2):202-13. PubMed ID: 23804554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.